Ignite Creation Date:
2024-05-06 @ 12:04 AM
Last Modification Date:
2024-10-26 @ 10:44 AM
Study NCT ID:
NCT01482767
Status:
COMPLETED
Last Update Posted:
2021-11-04
First Post:
2011-11-28
Brief Title:
Evaluating the Effectiveness of Boceprevir Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus HCV Infection in Adults With HIV and HCV Infection
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2015-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-04
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-28
First Submit QC Date:
November 28 2011
Study First Post Date:
2011-12-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2016-05-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-02
Last Update Post Date:
2021-11-04
Last Update Post Date Type:
ACTUAL